Should patients with HPV-positive or negative tumors be treated differently?

Current Oncology Reports

Volumn 16, Issue 5, 2014, Pages

  George, Monica ^a  

^a MEDWAY MARITIME HOSPITAL   (United Kingdom)

Author keywords

Head and neck cancer; HPV; HPV associated oropharyngeal cancers; HPV positive tumors; HPV related oropharyngeal squamous cell carcinomas; Oncology; Oropharyngeal squamous cell carcinomas

Indexed keywords

ANTINEOPLASTIC AGENT; CETUXIMAB; CISPLATIN; PACLITAXEL;

ARTICLE; CANCER CHEMOTHERAPY; CANCER PATIENT; CANCER RADIOTHERAPY; CANCER RISK; CANCER SURGERY; DRUG DOSE REDUCTION; HUMAN; MULTIMODALITY CANCER THERAPY; OROPHARYNX CANCER; RADIATION DOSE REDUCTION; SQUAMOUS CELL CARCINOMA; WART VIRUS; CANCER STAGING; OROPHARYNX TUMOR; PAPILLOMAVIRUS INFECTION; PROGNOSIS; REVIEW; RISK FACTOR; SURVIVAL; VIROLOGY;

CARCINOMA, SQUAMOUS CELL; HUMANS; NEOPLASM STAGING; OROPHARYNGEAL NEOPLASMS; PAPILLOMAVIRUS INFECTIONS; PROGNOSIS; RISK FACTORS; SURVIVAL ANALYSIS;

EID: 84897348488     PISSN: 15233790     EISSN: 15346269     Source Type: Journal    
DOI: 10.1007/s11912-014-0384-2     Document Type: Article

References (44)

1. Chaturvedi AK et al. Incidence trends for human papillomavirus-related and -unrelated oral squamous cell carcinomas in the United States. J Clin Oncol. 2008;26(4):612-9. (Pubitemid 351264356)
2. Ryerson AB et al. Burden of potentially human papillomavirus-associated cancers of the oropharynx and oral cavity in the US, 1998-2003. Cancer. 2008;113(10 Suppl):2901-9.
3. D'Souza G et al. Six-month natural history of oral versus cervical human papillomavirus infection. Int J Cancer. 2007;121(1):143-50. (Pubitemid 46753862)
4. Kreimer AR et al. HPV16 semiquantitative viral load and serologic biomarkers in oral and oropharyngeal squamous cell carcinomas. Int J Cancer. 2005;115(2):329-32. (Pubitemid 40586745)
5. Nasman A et al. Incidence of human papillomavirus (HPV) positive tonsillar carcinoma in Stockholm, Sweden: an epidemic of viral-induced carcinoma? Int J Cancer. 2009;125(2):362-6.
6. Braakhuis BJ et al. Genetic patterns in head and neck cancers that contain or lack transcriptionally active human papillomavirus. J Natl Cancer Inst. 2004;96(13):998-1006. (Pubitemid 39162642)
7. Klussmann JP et al. Genetic signatures of HPV-related and unrelated oropharyngeal carcinoma and their prognostic implications. Clin Cancer Res. 2009;15(5):1779-86.
8. Smeets SJ et al. Genome-wide DNA copy number alterations in head and neck squamous cell carcinomas with or without oncogene-expressing human papillomavirus. Oncogene. 2006;25(17):2558-64.
9. Martinez I et al. Identification of differentially expressed genes in HPV-positive and HPV-negative oropharyngeal squamous cell carcinomas. Eur J Cancer. 2007;43(2):415-32. (Pubitemid 46123982)
10. Westra WH et al. Inverse relationship between human papillomavirus-16 infection and disruptive p53 gene mutations in squamous cell carcinoma of the head and neck. Clin Cancer Res. 2008;14(2):366-9. (Pubitemid 351226102)
11. Kumar B et al. EGFR, p16, HPV Titer, Bcl-xL and p53, sex, and smoking as indicators of response to therapy and survival in oropharyngeal cancer. J Clin Oncol. 2008;26(19):3128-37.
12. Machtay M et al. Factors associated with severe late toxicity after concurrent chemoradiation for locally advanced head and neck cancer: an RTOG analysis. J Clin Oncol. 2008;26(21):3582-9.
13. Posner MR et al. Cisplatin and fluorouracil alone or with docetaxel in head and neck cancer. N Engl J Med. 2007;357(17):1705-15. (Pubitemid 350005152)
14. Vermorken JB et al. Cisplatin, fluorouracil, and docetaxel in unresectable head and neck cancer. N Engl J Med. 2007;357(17):1695-704. (Pubitemid 350005151)
15. Langendijk JA et al. Impact of Late Treatment-Related Toxicity on Quality of Life Among Patients With Head and Neck Cancer Treated With Radiotherapy. J Clin Oncol. 2008;26(22):3770-6.
16. Ang KK et al. Human papillomavirus and survival of patients with oropharyngeal cancer. N Engl J Med. 2010;363(1):24-35.
17. Huang SH et al. Natural course of distant metastases following radiotherapy or chemoradiotherapy in HPV-related oropharyngeal cancer. Oral Oncol. 2013;49(1):79-85.
18. O'Sullivan B et al. Deintensification candidate subgroups in human papillomavirus-related oropharyngeal cancer according to minimal risk of distant metastasis. J Clin Oncol. 2013;31(5):543-50.
19. Pignon J-P et al. Meta-analysis of chemotherapy in head and neck cancer (MACH-NC): An update on 93 randomised trials and 17,346 patients. Radiother Oncol J Eur Soc Ther Radiol Oncol. 2009;92(1):4-14.
20. Fakhry C et al. Improved survival of patients with human papillomavirus-positive head and neck squamous cell carcinoma in a prospective clinical trial. J Natl Cancer Inst. 2008;100(4):261-9. (Pubitemid 351480538)
21. Rischin D et al. Prognostic significance of p16INK4A and human papillomavirus in patients with oropharyngeal cancer treated on TROG 02.02 phase III trial. J Clin Oncol. 2010;28(27):4142-8.
22. Posner MR et al. Survival and human papillomavirus in oropharynx cancer in TAX 324: a subset analysis from an international phase III trial. Ann Oncol. 2011;22(5):1071-7.
23. Lassen P et al. Effect of HPV-associated p16INK4A expression on response to radiotherapy and survival in squamous cell carcinoma of the head and neck. J Clin Oncol. 2009;27(12):1992-8.
24. NCCN clinical practice guidelines in oncology. Head and neck cancers. Version 2.2013 [Internet]. 2013:06/09.
25. Forastiere AA. Chemotherapy in the treatment of locally advanced head and neck cancer. J Surg Oncol. 2008;97(8):701-7. (Pubitemid 351812972)
26. Koutcher L et al. Concurrent cisplatin and radiation versus cetuximab and radiation for locally advanced head-and-neck cancer. Int J Radiat Oncol Biol Phys. 2011;81(4):915-22.
27. Haughey BH et al. Transoral laser microsurgery as primary treatment for advanced-stage oropharyngeal cancer: a United States multicenter study. Head Neck. 2011;33(12):1683-94.
28. Moore EJ et al. Transoral resection of tonsillar squamous cell carcinoma. Laryngoscope. 2009;119(3):508-15.
29. Steiner W et al. Transoral laser microsurgery for squamous cell carcinoma of the base of the tongue. Arch Otolaryngol Head Neck Surg. 2003;129(1):36-43. (Pubitemid 36070874)
30. Grant DG et al. Carcinoma of the tongue base treated by transoral laser microsurgery, part two: Persistent, recurrent and second primary tumors. Laryngoscope. 2006;116(12):2156-61. (Pubitemid 44912311)
31. Henstrom DK et al. Transoral resection for squamous cell carcinoma of the base of the tongue. Arch Otolaryngol Head Neck Surg. 2009;135(12):1231-8.
32. Weinstein GS et al. Transoral robotic surgery for advanced oropharyngeal carcinoma. Arch Otolaryngol Head Neck Surg. 2010;136(11):1079-85.
33. Hurtuk A et al. Outcomes of transoral robotic surgery: a preliminary clinical experience. Otolaryngol Head Neck Surg. 2011;145(2):248-53.
34. Moore EJ et al. Long-term functional and oncologic results of transoral robotic surgery for oropharyngeal squamous cell carcinoma. Mayo Clin Proc. 2012;87(3):219-25.
35. Olsen SM et al. Transoral surgery alone for human-papillomavirus- associated oropharyngeal squamous cell carcinoma. Ear Nose Throat J. 2013;92(2):76-83.
36. Sinha P, et al. Transoral laser microsurgery for oral squamous cell carcinoma: Oncologic outcomes and prognostic factors. Head Neck. 2014;36(3):340-51. doi:10.1002/hed.23293.
37. Weinstein GS et al. Selective neck dissection and deintensified postoperative radiation and chemotherapy for oropharyngeal cancer: a subset analysis of the University of Pennsylvania transoral robotic surgery trial. Laryngoscope. 2010;120(9):1749-55.
38. Quon H et al. Transoral robotic surgery and adjuvant therapy for oropharyngeal carcinomas and the influence of p16 INK4a on treatment outcomes. Laryngoscope. 2013;123(3):635-40.
39. Genden EM et al. Human papillomavirus and oropharyngeal squamous cell carcinoma: what the clinician should know. Eur Arch Otorhinolaryngol. 2013;270(2):405-16.
40. Sinha P et al. Extracapsular spread and adjuvant therapy in human papillomavirus-related, p16-positive oropharyngeal carcinoma. Cancer. 2012;118(14):3519-30.
41. Moore EJ, Olsen KD, Kasperbauer JL. Transoral robotic surgery for oropharyngeal squamous cell carcinoma: a prospective study of feasibility and functional outcomes. Laryngoscope. 2009;119(11):2156-64.
42. Dowthwaite SA et al. The role of transoral robotic surgery in the management of oropharyngeal cancer: a review of the literature. ISRN Oncol. 2012;2012:945162.
43. Cohen MA et al. Transoral robotic surgery and human papillomavirus status: Oncologic results. Head Neck. 2011;33(4):573-80.
44. Nichols AC et al. Early-stage squamous cell carcinoma of the oropharynx: radiotherapy vs. trans-oral robotic surgery (ORATOR)-study protocol for a randomized phase II trial. BMC Cancer. 2013;13:133.